MAPT and depressive symptom measurement: Although it is hard to postulate their causative relationship among these correlations, they are the first clue for further investigation to determine the correlation of Aβ42/40 ratio and Tau-pT181 level with cognition/dementia or depression/anxiety during Alzheimer’s disease progression.